Dyadic International (DYAI) Tax Provisions (2018 - 2020)
Dyadic International (DYAI) posted Tax Provisions of $31318.0 for Q4 2020, up 232.96% sequentially from $9406.0 in Q4 2019, and up 232.96% YoY from $9406.0 in Q1 2020.
Dyadic International (DYAI) Tax Provisions (2018 - 2020) Analysis & Trends
Dyadic International has reported Tax Provisions for 3 years, with the latest figure at $31318.0 in Q4 2020.
- Quarterly Tax Provisions rose 232.96% year-over-year to $31318.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $31318.0 (up 203.88% YoY) and the FY2020 annual result came in at $31318.0, up 203.88% from the prior year.
- Tax Provisions rose to $31318.0 in Q4 2020 per DYAI's latest filing, from $9406.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $31318.0 in Q4 2020 and troughed at -$1.0 million in Q4 2018.
- A 3-year average of -$241133.2 and a median of $5153.0 in 2019 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2019 and 2020: Tax Provisions jumped 100.93% in 2019, then jumped 232.96% in 2020.
- Over 3 years, Tax Provisions stood at -$1.0 million in 2018, then soared by 100.93% to $9406.0 in 2019, then surged by 232.96% to $31318.0 in 2020.
- According to Business Quant data, Tax Provisions over the past three periods registered $31318.0, $9406.0, and $900.0 for Q4 2020, Q4 2019, and Q1 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 31,318.00 |
| Dec 31, 2019 | 9,406.00 |
| Mar 31, 2019 | 900.00 |
| Dec 31, 2018 | -1.01 Mn |